Bortenat-Bortezomib bortenat is formulated by using bortezomib and belongs to a class of medicines known as antineoplastic agents. It is for treating multiple myeloma and is also useful in curing mantle cell lymphoma. The medicine is very effective in these disease as it straightaway reacts with certain proteins in the body to arrest the growth of cancer cells. Supplied as available in 2mg & 3. 5mg single use vial. Overdose weakness, unusual bruising or bleeding, blurred vision, pinpoint red spots on your skin, and fainting. Precautions and Wwarnings doctor consultation required if the patient has diabetes, liver disease, or is on dialysis, a bleeding or blood clotting disorder, a low level of platelets or white or red blood cells, heart disease, congestive heart failure, herpes or a history of shingles, high or low blood pressure, or nerve problems such as burning, numbness, pain, or tingly feeling
- patients are advised not to take any immunization during this period, without doctor's consent
- drug interactions
- rifabutin, rifampin, rifapentine
- st. John's wort
- antibiotics (clarithromycin, erythromycin or telithromycin
in section "Pharmaceutical Ointments"
View also products categories "Ointments"